Skip to main content

Table 4 Bleeding events of In-Hospital and 12-Months Follow-Up

From: Efficacy and safety of standard and low dose ticagrelor versus clopidogrel in east AsianPatients with chronic total occlusion undergoing percutaneous coronary intervention: a single center retrospective study

VariablesTicagrelor 90 mg (n = 171)Ticagrelor 60 mg (n = 178)Clopidogrel 75 mg (n = 176)P-value
Bleedings in hospital
Major bleeding, n(%)2 (1.2%)1 (0.6%)1 (0.6%)0.699
Minor bleeding, n(%)31 (18.1%)18 (10.1%)16 (9.1%)0.021
Bleedings during 12-month follow-up
Major bleeding, n(%)7 (4.1%)1 (0.6%)1 (0.6%)0.016
Minor bleeding, n(%)40 (23.4)22 (12.4%)21 (11.9%)0.004